Congenital Cytomegalovirus Infection (Congenital CMV Infection)


Article Author:
Uduak Akpan


Article Editor:
Leela Sharath Pillarisetty


Editors In Chief:
Tod Aeby


Managing Editors:
Avais Raja
Orawan Chaigasame
Carrie Smith
Abdul Waheed
Khalid Alsayouri
Trevor Nezwek
Radia Jamil
Patrick Le
Anoosh Zafar Gondal
Saad Nazir
William Gossman
Hassam Zulfiqar
Hussain Sajjad
Steve Bhimji
Muhammad Hashmi
John Shell
Matthew Varacallo
Heba Mahdy
Ahmad Malik
Sarosh Vaqar
Mark Pellegrini
James Hughes
Beata Beatty
Beenish Sohail
Nazia Sadiq
Hajira Basit
Phillip Hynes


Updated:
6/17/2019 3:36:32 PM

Introduction

Congenital cytomegalovirus (CCMV) infection is the most common intrauterine infection in the U.S. and the most common cause of non-genetic sensorineural hearing loss in children.[1][2] Most of the time, the disease is asymptomatic (85 to 90%).[3][4] The symptomatic congenital disease occurs most often after primary maternal infection in pregnancy.  Although significantly less common, symptomatic CCMV carries a mortality risk of up to 7 to 12% in the early neonatal period. There is an increased risk of severe morbidity due to CNS damage, leading to neurodevelopmental delays, hearing loss, and vision impairment. Asymptomatic disease is not entirely benign as 10 to 15% go on to develop long term morbidities.[4][5] Despite these risks, there is poor awareness of CCMV among women of reproductive age.[6][7]

Etiology

Cytomegalovirus (CMV) is the largest member of the herpes viridae family (HHV-5), and humans are the main reservoir. The virus sheds in bodily fluids such as saliva, urine, breast milk, semen, and blood. Primary infection of the host occurs when a previously uninfected individual acquires the disease for the first time.  In addition to primary infection, there can also be latent or non-primary infections. Non-primary infections result from reactivation of a previous infection or infection with a different strain of the virus.[8] Hormonal changes associated with pregnancy and lactation may stimulate reactivation of CMV.  Primary infection is associated with the greatest risk of transplacental transmission (30 to 35%),[2][9] compared to 1.1 to 1.7% for non-primary infections.[10] However, due to the relatively high seroprevalence rates, CCMV usually results from non-primary maternal infections.[2][11]

An important risk factor for primary infection during pregnancy is prolonged exposure to young children.[12] CMV infected children under 2 years of age secrete the virus in their urine and saliva for about 24 months.[13] Shedding of CMV in urine and cervicovaginal secretions increases as pregnancy progress. Thus, the transmission of the disease is more likely at more advanced pregnancy stages (58 to 78% in the third trimester compared to 30 to 45% in the first trimester).[14][15] However, long-term sequelae are less likely to occur if the fetus is infected later in pregnancy (24 to 26% if infected in the first trimester, and 2.5 to 6% if infected after 20 weeks).[16][17]

Epidemiology

Seroprevalence rates in women of reproductive age differ based on socioeconomic status. In developed countries, the seroprevalence rate ranges from 40 to 83%,[18] but in developing countries, the seroprevalence rate is almost 100%.[10] However, in lower socioeconomic groups in developed countries, the seroprevalence rate approaches that seen in developing countries. Acquisition of CMV in industrialized nations is usually due to frequent contact with small children while in the developing world, transmission occurs early in life through breastfeeding and crowded living conditions.[19] The live birth prevalence rate in developed countries is 0.6 to 0.7%, resulting in about 40000 cases annually in the United States.[20] The incidence of CCMV is higher in developing countries – between 1 and 5%. However, only about 10% are symptomatic as neonates, making the disease difficult to detect. The risk of long-term neurological sequelae increases in symptomatic babies with 40-58% developing permanent sequelae such as sensorineural hearing loss, ophthalmological deficits, and neurodevelopmental delays.[21] The commonest complication of CCMV infection is hearing loss; 35% in symptomatic newborns and 7 to 10% in asymptomatic newborns.[19][22]

History and Physical

Maternal CMV infection is frequently asymptomatic. Primary infection cannot clinically be distinguished from Epstein Barr virus (EBV) infection and presents with symptoms that include fever, malaise, headache, pharyngitis, lymphadenopathy, hepatosplenomegaly, arthralgias, and rash.

Fetal abnormalities include intracranial calcifications, microcephaly, ventriculomegaly, lenticulostriate vasculopathy, occipital horn anomalies, echogenic bowel, intrauterine growth restriction, hepatomegaly, pericardial effusion, and ascites. Also noted are placental inflammation and fetal death.[2][23] The most common signs of congenital cytomegalovirus in the neonate are jaundice, petechiae, hepatosplenomegaly, and microcephaly.[4][5][20][24][25] Other findings include chorioretinitis with or without optic atrophy and cataracts. Newborns could be premature or small for gestational age, or both. Hearing loss, which is the hallmark of CCMV may be present at birth or present later in life; this underscores the importance of regular hearing screens in children affected by CCMV.

Laboratory findings include elevated aspartate transferase, conjugated hyperbilirubinemia, thrombocytopenia, and elevated CSF protein.[24] Cranial imaging findings include periventricular calcifications, ventricular dilatation, ventricular cysts, and lenticulostriate vasculopathy.[20][22]

Evaluation

Diagnosis can occurs in two settings – prenatal and postnatal. Prenatal diagnosis involves testing of the mother and fetus.

Universal screening for CMV in pregnancy is currently not a recommendation due to a lack of tests with high enough sensitivity and specificity, as well as limited options for intervention.  However, in certain circumstances, testing is advisable.  Such circumstances include mononucleosis-like illness in pregnancy, exposure to an individual with CMV infection, occupational exposure (health or childcare worker) or fetal ultrasound suggestive of congenital CMV infection such as the presence of ventriculomegaly, hyperechogenic bowel, intracranial calcifications, and hydrops.[26] In cases of suspected primary CMV infection, maternal and fetal testing is necessary.

Maternal testing involves determining the maternal antibody status.  A definitive diagnosis of primary CMV infection is obtained if there is seroconversion from a previously negative antibody status to an antibody positive status.[27] Since routine screening is not currently the standard of care, this conversion often gets missed.  The presence of IgM antibodies suggests primary infection; however, IgM antibodies can persist for several months. More sophisticated testing such as IgG antibody avidity testing is necessary for sorting out the timing of infection.  With recent infections, the avidity is low (antibodies bind less tightly with their protein); thus the presence of IgM levels along with a low IgG avidity index is highly suggestive of a recent primary infection.[8]

Fetal diagnosis is achieved via amniocentesis for amniotic fluid PCR with or without viral culture.  Replication of the virus in the fetal kidney, leading to shedding in the urine, occurs at least 5 to 7 weeks after infection.  Thus, the optimal time for performing this test is after 21 weeks gestation and 7 weeks after maternal infection.[8] The sensitivity of amniocentesis after 21 weeks is about 71% and 30% if done before 21 weeks.[28] A fetal sonogram is also a recommended procedure; however, the possible findings are not specific for CMV and are present in only around 15% of infected fetuses.[29] The presence of ultrasound abnormalities along with primary maternal infection strongly suggests fetal infection.[29] Cordocentesis for fetal IgM testing is not recommended due to poor sensitivity of the test and risk involved. A positive test on cordocentesis is always followed by a positive test on amniocentesis suggesting that amniocentesis without cord blood testing is adequate for diagnosing fetal CMV infection.[30] Viral load of CMV in the amniotic fluid may be determined for prognostic value.  Higher CMV DNA load over 100000 correlates with symptoms in the newborn.[31]

Unless there is a high index of suspicion, CCMV often goes undetected at birth since most infected newborns are asymptomatic. Testing involves isolation of virus from urine or saliva via culture or DNA PCR within the first 3 weeks of life. After 3 weeks, it is not possible to determine the timing of infection – congenital vs. intrapartum or postnatal from breast milk or blood transfusion. Intrapartum or postnatal disease are not usually associated with long term sequelae.[9] There is a risk of PCR contamination with CMV positive breast milk, so ideally testing should be done more than 1 hour after breastfeeding.[32] Further evaluation of a newborn with CCMV should include complete blood count, hepatic panel, serum bilirubin (total and direct), and cranial imaging (ultrasound as the first test, may be followed by MRI if needed).[25]

Treatment / Management

There is no definitive way to treat congenitally acquired CMV in utero. For fetuses with positive isolation of the virus, termination of the pregnancy can be offered to parents.  This offer must be accompanied with thorough counseling to enable the parents to make an informed decision.  If the parents opt to continue the pregnancy, close follow up with regular ultrasound exams is essential. The use of CMV hyperimmune globulin (CMV HIG) as a method of prevention, could reduce the number of congenitally infected newborns compared to no treatment.[33] However, since concerns remain as to efficacy and toxicity, routine use is not recommended.[34]

At birth, the newborn must be tested within 3 weeks of delivery via saliva or urine PCR or culture.  If the diagnosis is confirmed, close follow up should be ensured for symptomatic neonates. Asymptomatic neonates also required to follow up, in particular, regular hearing screens. Pediatric subspecialists that have a role to play in the care of congenitally infected neonates include audiologists, otolaryngologists, ophthalmologists, neurologists, development/behavior specialists, infectious disease specialists, and physical/occupational therapists.[25]

Neonates with symptomatic CCMV should receive oral valganciclovir for 6 months. This therapy has been shown to preserve normal hearing or prevent the progression of hearing loss, and also correlates with improved long-term neurodevelopmental outcomes.[35] Oral Valganciclovir is superior to intravenous Ganciclovir, which is associated with bone marrow suppression (manifesting as neutropenia) and gonadal toxicity.[36] For both asymptomatic and symptomatic newborns, close follow up is vital to monitor for the development of long-term sequelae.

Differential Diagnosis

Other TORCH infections include toxoplasmosis, rubella, HSV, and syphilis.[9][37] Toxoplasmosis usually presents with chorioretinitis, microphthalmia, hydrocephalus, scattered calcifications, and maculopapular rash. Newborns with congenital rubella syndrome have cataracts and congenital heart disease. A vesicular rash usually distinguishes Herpes simplex infection. Syphilis is associated with rhinitis and osteochondritis. Acute neonatal viral, bacterial, or fungal infections could mimic CCMV; as well as inborn errors of metabolism, such as galactosemia and tyrosinemia. A positive newborn metabolic screen would be the expectation, with inborn errors of metabolism. History and physical examination, bacterial, or fungal cultures would help distinguish other infections.

Prognosis

Prognosis is poor. Symptomatic congenital cytomegalovirus leads to long term sequelae including sensorineural hearing loss, mental and developmental disabilities, and impaired vision. Around 10% of symptomatic newborns will die in the neonatal period, a number that may be low. Asymptomatic babies are not spared long-term sequelae, with 10 to 12% developing hearing loss and a smaller percentage of developing neuromotor disabilities and vision problems.[21] Infants of mothers who acquired primary CMV in pregnancy or who are symptomatic with microcephaly, intracranial calcifications or chorioretinitis have the worst prognosis.[37]

Complications

Complications occur more commonly in symptomatic CMV infection. These include:

  • Sensorineural hearing loss: Most common complication and it affects both symptomatic and asymptomatic neonates
  • Neurodevelopmental delays: including motor deficits such as cerebral palsy, and cognitive deficits
  • Ophthalmological deficits: ranging from the clinical finding of chorioretinitis to optic atrophy that may be associated with vision loss
  • Seizures
  • Death

Deterrence and Patient Education

The greatest risk to pregnant women is exposure to urine or saliva of young children. Preventive steps that can reduce primary infection in pregnancy include education of pregnant women to increase awareness of CMV. Specific strategies that can be employed to decrease transmission include thorough hand washing after handling potentially infected articles, e.g., soiled diapers and toys, and limited intimate contact with children less than 6 years of age (such as kissing on the mouth or cheek, bed sharing, and wiping drool). Pregnant women should be counseled not to share utensils with their children or put a child’s pacifier in their mouth.[7][38][39] Childcare workers who plan to become pregnant may need to inform their employers so that the risk can be decreased as much as possible.

Enhancing Healthcare Team Outcomes

The primary care provider, nurse practitioner, obstetrician, infectious disease specialty trained nurse, and the pharmacist should operate in an interprofessional health team working with each other to educate the patient on CMV prevention, particularly in places where women are most at risk. Such facilities include obstetrics offices and childcare centers. Confirmed prenatal diagnosis or high suspicion of disease without confirmation should be communicated to the newborn medical team; to ensure neonatal testing, treatment if indicated, and appropriate follow up. Early diagnosis ensures access to treatment and early intervention services.


Interested in Participating?

We are looking for contributors to author, edit, and peer review our vast library of review articles and multiple choice questions. In as little as 2-3 hours you can make a significant contribution to your specialty. In return for a small amount of your time, you will receive free access to all content and you will be published as an author or editor in eBooks, apps, online CME/CE activities, and an online Learning Management System for students, teachers, and program directors that allows access to review materials in over 500 specialties.

Improve Content - Become an Author or Editor

This is an academic project designed to provide inexpensive peer-reviewed Apps, eBooks, and very soon an online CME/CE system to help students identify weaknesses and improve knowledge. We would like you to consider being an author or editor. Please click here to learn more. Thank you for you for your interest, the StatPearls Publishing Editorial Team.

Congenital Cytomegalovirus Infection (Congenital CMV Infection) - Questions

Take a quiz of the questions on this article.

Take Quiz
A 30-year-old G2P1001 woman is at her obstetrics provider for a routine prenatal visit, at 18 weeks of gestation. During the course of the visit, she mentions that a close friend of hers had an illness during which she had a fever, swollen lymph nodes, sore throat and a rash about 3 weeks before this visit. Her provider is concerned about Cytomegalovirus (CMV) exposure. Laboratory tests are ordered and the results confirm primary CMV infection. What is the next step in management?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
A newborn is found to have hepatosplenomegaly, microcephaly, and petechiae on physical exam. HIs laboratory results show thrombocytopenia and elevated liver enzymes. His mother works as a childcare provider in a daycare center. What subspecialist is essential as part of his follow up care?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
A one week old, small for gestational age neonate, was noted to have microcephaly and hepatosplenomegaly at birth. Prenatal ultrasounds had also detected periventricular calcifications. Saliva PCR for Cytomegalovirus (CMV) is positive. What information is crucial to include in the discharge instructions for the parents?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
A newborn with jaundice and thrombocytopenia undergoes a cranial ultrasound that shows periventricular calcifications. There is a cardiac murmur on examination. As these findings are discussed with the parents, they mention that they have a 3-year-old at home and two cats. Which of the following should be of greatest concern?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
A pregnant woman at 30 weeks gestation reported a flu-like illness to her provider. Suspecting Cytomegalovirus infection, laboratory testing was completed. The results showed positive CMV IgM antibodies with high avidity CMV IgG antibodies. Which of the following statements is true concerning this fetus after delivery?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
A pregnant woman with young children requests Cytomegalovirus (CMV) testing because she is worried that she is at risk. Her testing shows that she is seronegative for CMV. How should she be counseled?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
A 22-year -old G2P1 woman gives birth to a male neonate at 33 weeks of gestation. The pregnancy was uncomplicated, except for a finding of fetal echogenic bowel on an ultrasound exam at 20 weeks of gestation. His weight and length are at the 25th percentile, while his head measures less than the third percentile for his gestational age. Further examination reveals jaundice, ear tags on the right side, postaxial polydactyly bilaterally and generalized petechiae. Confirmatory testing is done, and treatment is started. Regular monitoring of which of the following is required?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
A 3-day old term neonate whose mother had preeclampsia is found to have thrombocytopenia. The baby is being breastfed and has lost 5% of his birth weight of 2240 g. On examination, he is jaundiced, microcephalic, and has scattered petechiae. What test is essential as part of the evaluation?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
A 6-month-old has a history of intrauterine growth retardation, microcephaly, prolonged neonatal jaundice, hepatosplenomegaly, and purpura. The child has had developmental delays. Radiographs show periventricular calcifications. What strategy may limit the effects of the most common complication of his disease?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
A 3-day old term neonate whose mother had preeclampsia is found to have thrombocytopenia. The baby is being breastfed and has lost 5% of his birth weight of 2240 grams. On physical examination, he is jaundiced, microcephalic, and has scattered petechiae. What test is essential as part of the evaluation?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up

Congenital Cytomegalovirus Infection (Congenital CMV Infection) - References

References

Lazzarotto T,Guerra B,Gabrielli L,Lanari M,Landini MP, Update on the prevention, diagnosis and management of cytomegalovirus infection during pregnancy. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases. 2011 Sep;     [PubMed]
Picone O,Vauloup-Fellous C,Cordier AG,Guitton S,Senat MV,Fuchs F,Ayoubi JM,Grangeot Keros L,Benachi A, A series of 238 cytomegalovirus primary infections during pregnancy: description and outcome. Prenatal diagnosis. 2013 Aug;     [PubMed]
Boppana SB,Pass RF,Britt WJ,Stagno S,Alford CA, Symptomatic congenital cytomegalovirus infection: neonatal morbidity and mortality. The Pediatric infectious disease journal. 1992 Feb;     [PubMed]
Kylat RI,Kelly EN,Ford-Jones EL, Clinical findings and adverse outcome in neonates with symptomatic congenital cytomegalovirus (SCCMV) infection. European journal of pediatrics. 2006 Nov;     [PubMed]
Lanzieri TM,Leung J,Caviness AC,Chung W,Flores M,Blum P,Bialek SR,Miller JA,Vinson SS,Turcich MR,Voigt RG,Demmler-Harrison G, Long-term outcomes of children with symptomatic congenital cytomegalovirus disease. Journal of perinatology : official journal of the California Perinatal Association. 2017 Jul;     [PubMed]
Jeon J,Victor M,Adler SP,Arwady A,Demmler G,Fowler K,Goldfarb J,Keyserling H,Massoudi M,Richards K,Staras SA,Cannon MJ, Knowledge and awareness of congenital cytomegalovirus among women. Infectious diseases in obstetrics and gynecology. 2006;     [PubMed]
Cannon MJ,Westbrook K,Levis D,Schleiss MR,Thackeray R,Pass RF, Awareness of and behaviors related to child-to-mother transmission of cytomegalovirus. Preventive medicine. 2012 May;     [PubMed]
Revello MG,Gerna G, Diagnosis and management of human cytomegalovirus infection in the mother, fetus, and newborn infant. Clinical microbiology reviews. 2002 Oct;     [PubMed]
Pass RF, Cytomegalovirus infection. Pediatrics in review. 2002 May;     [PubMed]
Kenneson A,Cannon MJ, Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection. Reviews in medical virology. 2007 Jul-Aug;     [PubMed]
Wang C,Zhang X,Bialek S,Cannon MJ, Attribution of congenital cytomegalovirus infection to primary versus non-primary maternal infection. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2011 Jan 15;     [PubMed]
Bristow BN,O'Keefe KA,Shafir SC,Sorvillo FJ, Congenital cytomegalovirus mortality in the United States, 1990-2006. PLoS neglected tropical diseases. 2011 Apr 26;     [PubMed]
Adler SP,Nigro G,Pereira L, Recent advances in the prevention and treatment of congenital cytomegalovirus infections. Seminars in perinatology. 2007 Feb;     [PubMed]
Bodéus M,Kabamba-Mukadi B,Zech F,Hubinont C,Bernard P,Goubau P, Human cytomegalovirus in utero transmission: follow-up of 524 maternal seroconversions. Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology. 2010 Feb;     [PubMed]
Enders G,Daiminger A,Bäder U,Exler S,Enders M, Intrauterine transmission and clinical outcome of 248 pregnancies with primary cytomegalovirus infection in relation to gestational age. Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology. 2011 Nov;     [PubMed]
Pass RF,Fowler KB,Boppana SB,Britt WJ,Stagno S, Congenital cytomegalovirus infection following first trimester maternal infection: symptoms at birth and outcome. Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology. 2006 Feb;     [PubMed]
Revello MG,Zavattoni M,Furione M,Lilleri D,Gorini G,Gerna G, Diagnosis and outcome of preconceptional and periconceptional primary human cytomegalovirus infections. The Journal of infectious diseases. 2002 Aug 15;     [PubMed]
Yinon Y,Farine D,Yudin MH, Screening, diagnosis, and management of cytomegalovirus infection in pregnancy. Obstetrical     [PubMed]
Manicklal S,Emery VC,Lazzarotto T,Boppana SB,Gupta RK, The     [PubMed]
de Vries LS,Gunardi H,Barth PG,Bok LA,Verboon-Maciolek MA,Groenendaal F, The spectrum of cranial ultrasound and magnetic resonance imaging abnormalities in congenital cytomegalovirus infection. Neuropediatrics. 2004 Apr;     [PubMed]
Dollard SC,Grosse SD,Ross DS, New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infection. Reviews in medical virology. 2007 Sep-Oct;     [PubMed]
Boppana SB,Ross SA,Fowler KB, Congenital cytomegalovirus infection: clinical outcome. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2013 Dec;     [PubMed]
La Torre R,Nigro G,Mazzocco M,Best AM,Adler SP, Placental enlargement in women with primary maternal cytomegalovirus infection is associated with fetal and neonatal disease. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2006 Oct 15;     [PubMed]
Dreher AM,Arora N,Fowler KB,Novak Z,Britt WJ,Boppana SB,Ross SA, Spectrum of disease and outcome in children with symptomatic congenital cytomegalovirus infection. The Journal of pediatrics. 2014 Apr;     [PubMed]
Schleiss MR, Congenital cytomegalovirus: Impact on child health. Contemporary pediatrics. 2018 Jul;     [PubMed]
Liesnard C,Donner C,Brancart F,Gosselin F,Delforge ML,Rodesch F, Prenatal diagnosis of congenital cytomegalovirus infection: prospective study of 237 pregnancies at risk. Obstetrics and gynecology. 2000 Jun;     [PubMed]
Guerra B,Simonazzi G,Puccetti C,Lanari M,Farina A,Lazzarotto T,Rizzo N, Ultrasound prediction of symptomatic congenital cytomegalovirus infection. American journal of obstetrics and gynecology. 2008 Apr;     [PubMed]
Azam AZ,Vial Y,Fawer CL,Zufferey J,Hohlfeld P, Prenatal diagnosis of congenital cytomegalovirus infection. Obstetrics and gynecology. 2001 Mar;     [PubMed]
Guerra B,Lazzarotto T,Quarta S,Lanari M,Bovicelli L,Nicolosi A,Landini MP, Prenatal diagnosis of symptomatic congenital cytomegalovirus infection. American journal of obstetrics and gynecology. 2000 Aug;     [PubMed]
Naing ZW,Scott GM,Shand A,Hamilton ST,van Zuylen WJ,Basha J,Hall B,Craig ME,Rawlinson WD, Congenital cytomegalovirus infection in pregnancy: a review of prevalence, clinical features, diagnosis and prevention. The Australian     [PubMed]
Nigro G,Adler SP,La Torre R,Best AM, Passive immunization during pregnancy for congenital cytomegalovirus infection. The New England journal of medicine. 2005 Sep 29;     [PubMed]
Revello MG,Lazzarotto T,Guerra B,Spinillo A,Ferrazzi E,Kustermann A,Guaschino S,Vergani P,Todros T,Frusca T,Arossa A,Furione M,Rognoni V,Rizzo N,Gabrielli L,Klersy C,Gerna G, A randomized trial of hyperimmune globulin to prevent congenital cytomegalovirus. The New England journal of medicine. 2014 Apr 3;     [PubMed]
Rawlinson WD,Hamilton ST,van Zuylen WJ, Update on treatment of cytomegalovirus infection in pregnancy and of the newborn with congenital cytomegalovirus. Current opinion in infectious diseases. 2016 Dec;     [PubMed]
Lackner A,Acham A,Alborno T,Moser M,Engele H,Raggam RB,Halwachs-Baumann G,Kapitan M,Walch C, Effect on hearing of ganciclovir therapy for asymptomatic congenital cytomegalovirus infection: four to 10 year follow up. The Journal of laryngology and otology. 2009 Apr;     [PubMed]
Leung AK,Sauve RS,Davies HD, Congenital cytomegalovirus infection. Journal of the National Medical Association. 2003 Mar;     [PubMed]
Cannon MJ,Davis KF, Washing our hands of the congenital cytomegalovirus disease epidemic. BMC public health. 2005 Jun 20;     [PubMed]
Adler SP,Finney JW,Manganello AM,Best AM, Prevention of child-to-mother transmission of cytomegalovirus among pregnant women. The Journal of pediatrics. 2004 Oct;     [PubMed]
Johnson J,Anderson B,Pass RF, Prevention of maternal and congenital cytomegalovirus infection. Clinical obstetrics and gynecology. 2012 Jun;     [PubMed]
Rawlinson WD,Boppana SB,Fowler KB,Kimberlin DW,Lazzarotto T,Alain S,Daly K,Doutré S,Gibson L,Giles ML,Greenlee J,Hamilton ST,Harrison GJ,Hui L,Jones CA,Palasanthiran P,Schleiss MR,Shand AW,van Zuylen WJ, Congenital cytomegalovirus infection in pregnancy and the neonate: consensus recommendations for prevention, diagnosis, and therapy. The Lancet. Infectious diseases. 2017 Jun;     [PubMed]

Disclaimer

The intent of StatPearls is to provide practice questions and explanations to assist you in identifying and resolving knowledge deficits. These questions and explanations are not intended to be a source of the knowledge base of all of medicine, nor is it intended to be a board or certification review of Ob Gyn-Medical Student. The authors or editors do not warrant the information is complete or accurate. The reader is encouraged to verify each answer and explanation in several references. All drug indications and dosages should be verified before administration.

StatPearls offers the most comprehensive database of free multiple-choice questions with explanations and short review chapters ever developed. This system helps physicians, medical students, dentists, nurses, pharmacists, and allied health professionals identify education deficits and learn new concepts. StatPearls is not a board or certification review system for Ob Gyn-Medical Student, it is a learning system that you can use to help improve your knowledge base of medicine for life-long learning. StatPearls will help you identify your weaknesses so that when you are ready to study for a board or certification exam in Ob Gyn-Medical Student, you will already be prepared.

Our content is updated continuously through a multi-step peer review process that will help you be prepared and review for a thorough knowledge of Ob Gyn-Medical Student. When it is time for the Ob Gyn-Medical Student board and certification exam, you will already be ready. Besides online study quizzes, we also publish our peer-reviewed content in eBooks and mobile Apps. We also offer inexpensive CME/CE, so our content can be used to attain education credits while you study Ob Gyn-Medical Student.